Jamie Chaft

Jamie Chaft

UNVERIFIED PROFILE

Are you Jamie Chaft?   Register this Author

Register author
Jamie Chaft

Jamie Chaft

Publications by authors named "Jamie Chaft"

Are you Jamie Chaft?   Register this Author

74Publications

3005Reads

11Profile Views

Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer.

Radiother Oncol 2019 Nov 28;144:101-104. Epub 2019 Nov 28.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2019.11.015DOI Listing
November 2019

Outcomes of Stage III NSCLC with occult primary vs. known primary lesions.

Lung Cancer 2019 01 17;127:34-36. Epub 2018 Nov 17.

Memorial Sloan Kettering Cancer Center, Radiation Oncology, New York, NY 10065, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.11.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336108PMC
January 2019

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer.

J Clin Oncol 2018 10 20;36(28):2872-2878. Epub 2018 Aug 20.

Matthew D. Hellmann, Parker Institute for Cancer Immunotherapy; Kathryn C. Arbour, Niamh Long, Hira Rizvi, Andy Ni, W. Victoria Lai, Joshua K. Sabari, Andrew J. Plodkowski, Darragh Halpenny, Jamie E. Chaft, Gregory J. Riely, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center; Kathryn C. Arbour, W. Victoria Lai, Joshua K. Sabari, Jamie E. Chaft, Gregory J. Riely, and Matthew D. Hellmann, Weill Cornell Medical College, New York, NY; Laura Mezquita, Roberto Ferrara, Lizza E.L. Hendriks, Caroline Caramella, Benjamin Besse, and David Planchard, Gustave Roussy Cancer Center, Villejuif; Edouard Auclin, Hôpital Européen Georges Pompidou; Benjamin Besse, Paris-Sud University, Le Kremlin Bicêtre, Paris, France; Gala Martínez-Bernal, Virgen del Rocío Hospital, Seville, Spain; Lizza E.L. Hendriks, Maastricht University Medical Center, Maastricht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.79.0006DOI Listing
October 2018

Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer.

Ann Thorac Surg 2018 09 26;106(3):848-855. Epub 2018 May 26.

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2018.04.064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136648PMC
September 2018

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC.

Cancer Immunol Res 2018 09 10;6(9):1093-1099. Epub 2018 Jul 10.

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0755DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125223PMC
September 2018

Clinical outcomes of patients with resected, early-stage ALK-positive lung cancer.

Lung Cancer 2018 08 22;122:67-71. Epub 2018 May 22.

Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.05.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062851PMC
August 2018

Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Cancer Cell 2018 05 12;33(5):843-852.e4. Epub 2018 Apr 12.

Department of Medicine, Memorial Sloan Kettering Cancer Center, 885 2(nd) Avenue, New York, NY 10017, USA; Weill Cornell School of Medicine, New York, NY, USA; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183012
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.03.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953836PMC
May 2018

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

N Engl J Med 2018 May 16;378(21):1976-1986. Epub 2018 Apr 16.

From the Bloomberg-Kimmel Institute for Cancer Immunotherapy and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore (P.M.F., K.N.S., V.A., T.R.C., M.Z., S.C.Y., S.B., R.J.B., J.N., K.A.M., F.V., H.G., J.Z., J.X.C., H.Y.C., J.-W.S., R.B.S., J.W., E.G., H.W., G.L.R., J.M.T., V.E.V., S.L.T., J.R.B., D.M.P.); Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine (J.E.C., M.D.H., D.R.J., M.J.V., N.R., Z.O., V.R., J.D.W., T.M.) and the Ludwig Collaborative (J.D.W., T.M.) - all in New York; the Parker Institute for Cancer Immunotherapy, San Francisco (J.D.W., T.M.); and Swim Across America Laboratory, Charlotte, NC (J.D.W., T.M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1716078
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1716078DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223617PMC
May 2018

KEYNOTE-024: Unlocking a pathway to lung cancer cure?

J Thorac Cardiovasc Surg 2018 04 23;155(4):1777-1780. Epub 2017 Dec 23.

Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00225223173302
Publisher Site
http://dx.doi.org/10.1016/j.jtcvs.2017.10.155DOI Listing
April 2018

Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.

J Clin Oncol 2018 03 16;36(7):633-641. Epub 2018 Jan 16.

Hira Rizvi, Francisco Sanchez-Vega, Konnor La, Walid Chatila, Philip Jonsson, Darragh Halpenny, Andrew Plodkowski, Niamh Long, Jennifer L. Sauter, Natasha Rekhtman, Travis Hollmann, Ronglai Shen, Ai Ni, Kathryn C. Arbour, Taha Merghoub, Jedd Wolchok, Jamie E. Chaft, Mark G. Kris, Charles M. Rudin, Nicholas D. Socci, Michael F. Berger, Barry S. Taylor, Ahmet Zehir, David B. Solit, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely, Nikolaus Schultz, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center; Taha Merghoub, Jedd Wolchok, Alexandra Snyder, Jamie E. Chaft, Mark G. Kris, Charles M. Rudin, Gregory J. Riely, and Matthew D. Hellmann, Weill Cornell Medical College, New York, NY; Kurt A. Schalper, Yale School of Medicine, New Haven, CT; Justin F. Gainor, Massachusetts General Hospital, Boston, MA; and Alexandra Snyder, Adaptive Biotechnologies, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.3384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075848PMC
March 2018

Immunotherapy in surgically resectable non-small cell lung cancer.

J Thorac Dis 2018 Feb;10(Suppl 3):S404-S411

Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.12.93DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861266PMC
February 2018

Liquid biopsy for ctDNA to revolutionize the care of patients with early stage lung cancers.

Ann Transl Med 2017 Dec;5(23):479

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://atm.amegroups.com/article/view/16865/17870
Publisher Site
http://dx.doi.org/10.21037/atm.2017.09.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733322PMC
December 2017

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.

J Clin Oncol 2017 Sep 24;35(25):2960-2974. Epub 2017 Apr 24.

Mark G. Kris and Jamie E. Chaft, Memorial Sloan Kettering Cancer Center; Harvey I. Pass, New York University Langone Medical Center, New York; Rahul Seth, Upstate Medical Center, Syracuse University, Syracuse, NY; Laurie E. Gaspar and Michael Weyant, University of Colorado School of Medicine, Aurora, CO; Erin B. Kennedy, American Society of Clinical Oncology, Alexandria, VA; Christopher G. Azzoli, Massachusetts General Hospital, Boston, MA; Steven H. Lin, MD Anderson Cancer Center; John R. Strawn, Patient Representative, Houston, TX; David R. Spigel, Sarah Cannon Cancer Center, Nashville, TN; Peter M. Ellis, Juravinski Cancer Center, Hamilton Health Sciences, Hamilton; Frances A. Shepherd, Princess Margaret Cancer Centre, University Health Network; and Yee C. Ung, Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.4401DOI Listing
September 2017

Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors.

Ann Thorac Surg 2017 Sep;104(3):e217-e218

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2017.03.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572805PMC
September 2017

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).

J Clin Oncol 2017 Aug 13;35(24):2781-2789. Epub 2017 Jun 13.

Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne; Martin Früh, Kantonsspital St Gallen, St Gallen, Switzerland; Scott Gettinger, Yale Cancer Center, New Haven, CT; Melissa L. Johnson, Sarah Cannon Research Institute, Nashville, TN; Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA; Marina C. Garassino, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Daniel Christoph, Universitätsklinikum Essen, and the Ruhrlandklinik, Universität Duisburg-Essen, Essen; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany; Chee Keong Toh, National Cancer Centre, Singapore, Singapore; Naiyer A. Rizvi and Jamie E. Chaft, Memorial Sloan Kettering Cancer Center; Jamie E. Chaft, Weill Cornell Medical College, New York, NY; Enric Carcereny Costa, Catalan Institute of Oncology Badalona, Badalona; Luis Paz-Ares, Hospital Universitario Doce de Octubre & IIS i+12, CNIO, Ciberonc and Universidad Complutense, Madrid; Enriqueta Felip, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Jyoti D. Patel, University of Chicago, Chicago, IL; Laura Q.M. Chow, University of Washington, Seattle, WA; Marianna Koczywas, City of Hope, Duarte; Zhengrong Li, Jiaheng Qiu, Marcin Kowanetz, Simonetta Mocci, Geetha Shankar, and Alan Sandler, Genentech, South San Francisco, CA; Cheryl Ho, Vancouver Centre, BC Cancer Agency, Vancouver, British Columbia; Jeffrey Rothenstein, R.S. McLaughlin Durham Regional Cancer Centre, Oshawa; Frances A. Shepherd, Princess Margaret Cancer Centre/University Health Network and University of Toronto, Toronto, Ontario, Canada; Michel van den Heuvel, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; and Takayasu Kurata, Kansai Medical University Hirakata Hospital, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.9476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562171PMC
August 2017

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stages I to IIIA Resectable Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update Summary.

J Oncol Pract 2017 07 25;13(7):449-451. Epub 2017 Apr 25.

University of Colorado School of Medicine, Anschutz, CO; Memorial Sloan Kettering Cancer Center, New York City, NY; and American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.022251DOI Listing
July 2017

Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.

Lung Cancer 2017 06 28;108:205-211. Epub 2017 Mar 28.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 E 66(th) St., New York, NY 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave., New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.03.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423973PMC
June 2017

Definitive Radiotherapy for Local Recurrence of NSCLC After Surgery.

Clin Lung Cancer 2017 05 21;18(3):e161-e168. Epub 2017 Feb 21.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.01.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413410PMC
May 2017

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer.

Transl Lung Cancer Res 2017 Apr;6(2):178-185

Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.03.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420541PMC
April 2017

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

J Clin Oncol 2017 Mar 30;35(7):709-717. Epub 2016 Sep 30.

Jarushka Naidoo, Kaitlin M. Woo, Tunc Iyriboz, Darragh Halpenny, Jane Cunningham, Jamie E. Chaft, Neil H. Segal, Margaret K. Callahan, Alexander M. Lesokhin, Jonathan Rosenberg, Martin H. Voss, Charles M. Rudin, Hira Rizvi, Xue Hou, Katherine Rodriguez, Melanie Albano, Ruth-Ann Gordon, Charles Leduc, Natasha Rekhtman, Bianca Harris, Jedd D. Wolchok, Michael A. Postow, and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center; Jamie E. Chaft, Neil H. Segal, Margaret K. Callahan, Alexander M. Lesokhin, Jonathan Rosenberg, Martin H. Voss, Charles M. Rudin, Jedd D. Wolchok, Michael A. Postow, and Matthew D. Hellmann, Weill Cornell Medical College, New York, NY; Jarushka Naidoo, Sidney Kimmel Cancer Center at Johns Hopkins University, Baltimore, MD; Xuan Wang, Peking University Cancer Hospital and Institute, Beijing; Xue Hou, Sun Yat-sen University Cancer Center, Guangdong Province, People's Republic of China; Xuan Wang, Matteo S. Carlino, Benjamin Y. Kong, and Georgina V. Long, The University of Sydney; Alexander M. Menzies and Alexander D. Guminski, Royal North Shore and Mater Hospital; and Matteo S. Carlino and Benjamin Y. Kong, Westmead and Blacktown Hospitals, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559901PMC
March 2017

Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers.

Lung Cancer 2016 09 31;99:53-6. Epub 2016 May 31.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, NY, USA; Sydney Medical School, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.05.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305295PMC
September 2016

Have adjuvant tyrosine kinase inhibitors lost their shine?

Ann Transl Med 2016 Aug;4(15):285

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2016.07.18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980379PMC
August 2016

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.

Cancer Immunol Res 2016 05 29;4(5):383-9. Epub 2016 Feb 29.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241697PMC
May 2016

Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.

J Thorac Oncol 2016 Apr 25;11(4):537-44. Epub 2015 Dec 25.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.12.104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808609PMC
April 2016

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers.

J Thorac Oncol 2016 Mar 24;11(3):414-9. Epub 2015 Dec 24.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Diagnostics Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698879PMC
March 2016

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer.

Ann Thorac Surg 2016 Mar 12;101(3):1052-9. Epub 2016 Jan 12.

Thoracic Service, Department of Surgery, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2015.09.099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837652PMC
March 2016

Chemotherapy for lung cancers: here to stay.

Am Soc Clin Oncol Educ Book 2014 :e375-80

From the Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e375DOI Listing
December 2015

Impact of Concurrent PIK3CA Mutations on Response to EGFR Tyrosine Kinase Inhibition in EGFR-Mutant Lung Cancers and on Prognosis in Oncogene-Driven Lung Adenocarcinomas.

J Thorac Oncol 2015 Dec;10(12):1713-9

*Thoracic Oncology Service, Department of Medicine, †Department of Epidemiology and Biostatistics, ‡Department of Radiology, and §Department of Pathology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153509
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000671DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4760768PMC
December 2015

HER2 insertion YVMA mutant lung cancer: Long natural history and response to afatinib.

Lung Cancer 2015 Dec 29;90(3):617-9. Epub 2015 Oct 29.

Sydney Medical School, University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.10.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724317PMC
December 2015

Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival.

J Clin Oncol 2015 Sep 10;33(26):2877-84. Epub 2015 Aug 10.

Hideki Ujiie, Kyuichi Kadota, Daniel Buitrago, Camelia S. Sima, Ming-Ching Lee, James Huang, William D. Travis, Nabil P. Rizk, David R. Jones, and Prasad S. Adusumilli, Memorial Sloan Kettering Cancer Center; Jamie E. Chaft and Charles M. Rudin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; and Hideki Ujiie, Chiba University, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.60.9818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554749PMC
September 2015

Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation.

Clin Lung Cancer 2014 Nov 21;15(6):405-10. Epub 2014 Jun 21.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.06.002DOI Listing
November 2014

Serpins promote cancer cell survival and vascular co-option in brain metastasis.

Cell 2014 Feb;156(5):1002-16

Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Metastasis Research Center, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Howard Hughes Medical Institute, Chevy Chase, MD 21205, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2014.01.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988473PMC
February 2014

Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers.

Cancer Chemother Pharmacol 2013 Oct 22;72(4):931-4. Epub 2013 Aug 22.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 300 E, 66th Street, New York, NY, 10065, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2263-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841970PMC
October 2013

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.

Cancer Chemother Pharmacol 2013 Aug 28;72(2):453-61. Epub 2013 Jun 28.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical School, 300 East 66th Street, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2219-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653739PMC
August 2013

Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinomas.

Cancer 2013 Jan 18;119(2):356-62. Epub 2012 Jul 18.

Feinberg School of Medicine, Northwestern University, The Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27730DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966555PMC
January 2013

Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers.

J Thorac Oncol 2013 Jan;8(1):123-5

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31827914eaDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534987PMC
January 2013

Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib.

J Thorac Oncol 2012 Dec;7(12):1815-1822

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31826bb7b2DOI Listing
December 2012

Clinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung.

J Thorac Oncol 2012 Sep;7(9):1400-5

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182614856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632635PMC
September 2012

ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma.

J Thorac Oncol 2012 Apr;7(4):768-9

Thoracic Oncology Service, Division of Solid Tumor, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31824c9485DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690308PMC
April 2012

Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling.

Mol Cancer Ther 2012 Feb 1;11(2):485-91. Epub 2011 Dec 1.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-11
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-11-0692DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593239PMC
February 2012

Incorporation of crizotinib into the NCCN guidelines.

J Natl Compr Canc Netw 2011 Dec;9(12):1328-30

Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2011.0113DOI Listing
December 2011

Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design.

Clin Cancer Res 2011 Oct 19;17(19):6298-303. Epub 2011 Aug 19.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1468DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756539PMC
October 2011

Genetics of vascular anomalies: an update.

Lymphat Res Biol 2003 ;1(4):283-9

Department of Pediatrics, (Division of Hematology/Oncology), NYU Medical Center, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/153968503322758085DOI Listing
January 2005

Prenatal diagnosis of vascular anomalies: update and review of the literature.

Lymphat Res Biol 2003 ;1(4):309-12

New York University School of Medicine, NYU Medical Center, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/153968503322758111DOI Listing
January 2005